NCT07426198 - The Effect of Oral Care With Propolis in COPD Patients | Crick

Overview

The study was conducted in intensive care units and included patients diagnosed with COPD. The study was conducted with a total of 60 COPD patients, 30 in the intervention group and 30 in the control group. Individuals in the intervention group were given an oral care protocol containing propolis for 15 days, in addition to the clinic's standard oral care protocol. The control group continued to receive standard oral care. Oral mucosa was assessed on days 1, 7 and 15.

The study was conducted in intensive care units and included patients diagnosed with COPD. The study was conducted with a total of 60 COPD patients, 30 in the intervention group and 30 in the control group. Individuals in the intervention group were given an oral care protocol containing propolis for 15 days, in addition to the clinic's standard oral care protocol. The control group continued to receive standard oral care. Oral mucosa was assessed on days 1, 7 and 15 using the World Health Organization (WHO) Oral Mucositis Scoring Index and the Oral Assessment Guide (Oral Mucosa Score, OMS).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

60

Conditions

Oral Mucositis

Interventions

Oral care with propolisOTHER

Individuals in the intervention group were given an oral care protocol containing propolis for 15 days, in addition to the clinic's standard oral care protocol.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged 18 years or older, * diagnosed with COPD, * no oral mucositis at the start of the study, * no known allergy to bees or bee products, * able to speak and understand Turkish and communicate effectively, * conscious, * without any psychiatric illness, * without any mental or physical disability that would prevent them from answering questions, * individuals who volunteered to participate in the study were included in the study. Exclusion Criteria: * individuals with a cancer diagnosis, * individuals receiving immunosuppressive therapy, * individuals receiving mechanical ventilation support, * individuals with altered consciousness or acute confusion, * individuals who did not volunteer to participate in the study were excluded from the research.

Locations (1)

Erciyes University

Talas, Kayseri, Turkey (Türkiye)

Outcomes

Primary Outcomes

World Health Organization Oral Mucositis Scoring Index

The WHO Oral Mucositis Scoring Index rates the severity of mucositis on a scale of 0 to 4. Grade 0 indicates no mucositis; grade 1 indicates mild mucositis, grade 2 indicates moderate mucositis, and grades 3 and 4 indicate severe mucositis.

Time frame: The 1st, 7th, and 15th days were evaluated.

Oral Assessment Guide

Each assessment area is scored on a scale of 1, 2, or 3 points based on the severity of changes in the oral mucosa. All points obtained from the eight areas are added together to calculate the Total Oral Mucosa Score (OMP). An increase in the total score indicates worsening of oral mucosal damage and associated clinical symptoms. The lowest possible score from the guide is 8, and the highest is 24.

Time frame: The 1st, 7th, and 15th days were evaluated.